Physics

Internal medicine

Mycoplasma

Disease

Mycoplasma pneumoniae

Coronavirus disease 2019 (COVID-19)

Infectious disease (medical specialty)

Incidence (geometry)

Biology

Microbiology

Pandemic

Optics

Psychiatry

Virology

Psychological intervention

Respiratory tract infections

MEDLINE

Pneumonia

Scopus

Respiratory system

Biochemistry

Medicine

The Lancet Microbe

Mycoplasma pneumoniae is a major bacterial cause of respiratory tract infection.1 In early 2021, we established a collaborative global network to assess the effect of non-pharmaceutical interventions against COVID-19 on the transmission of M pneumoniae. Data collected through this network showed a significantly reduced incidence of M pneumoniae in the first year after the implementation of non-pharmaceutical interventions (1·69%; April 1, 2020–March 31, 2021) compared with previous years (8·61%; 2017–20),2 as observed for other respiratory infections.

Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?